Exosomal miR-17-5p from Human Embryonic Stem Cells Prevents Pulmonary Fibrosis by Targeting Thrombospondin-2

The authors established a bleomycin (BLM)-induced pulmonary fibrosis mice model and administered human embryonic stem cell exosomes from the first day after BLM treatment.